Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis

Arch Neurol. 2008 Aug;65(8):1114-6. doi: 10.1001/archneur.65.8.1114.


Background: Multiple sclerosis (MS) and fragile X-associated tremor/ataxia syndrome (FXTAS) have overlapping clinical signs and symptoms.

Objectives: To present a case with evidence of both MS and FXTAS and to discuss the relationship of both disorders.

Design: Case report.

Setting: Fragile X Research and Treatment Center at the University of California, Davis, Medical Center. Patient Woman with the FMR1 premutation who died of MS at the age of 52 years.

Main outcome measures: Magnetic resonance imaging, physical examination, and neuropathologic examination results.

Results: Magnetic resonance imaging, physical examination, and autopsy neuropathologic examination revealed diagnostic features of MS and FXTAS.

Conclusion: The molecular mechanism of RNA toxicity, including the elevation of alphaB-crystallin levels observed in FXTAS, may lead to enhanced predisposition to autoimmune diseases.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Fatal Outcome
  • Female
  • Fragile X Mental Retardation Protein / genetics*
  • Fragile X Syndrome / genetics
  • Fragile X Syndrome / pathology
  • Humans
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / genetics*
  • Multiple Sclerosis, Relapsing-Remitting / pathology*
  • Mutation / genetics*


  • FMR1 protein, human
  • Fragile X Mental Retardation Protein